Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Am J Prev Med. 2018 Mar 15;54(5):e83–e89. doi: 10.1016/j.amepre.2018.01.025

Table 4.

Predicted Daily Means (95% CI) Moderate to Vigorous Physical Activity by Treatment Phase and Average Day Length for Each Season

Fixed day lengtha /Treatment group Baseline Follow-up Change from baseline to follow-up
9.8 hours
 Increase PA 28.8 36.4 7.62 (3.10, 11.24)
 Decrease SB 28.8 31.5 2.65 (−0.81, 6.12)
 Difference 4.96 (0.20, 9.73)
13.3 hours
 Increase PA 28.3 42.9 14.65 (12.27, 17.03)
 Decrease SB 28.3 30.1 1.87 (−0.55, 4.28)
 Difference 12.78 (9.47, 16.10)
14.6 hours
 Increase PA 28.1 45.3 17.26 (14.08, 20.43)
 Decrease SB 28.1 29.6 1.57 (−1.70, 4.85)
 Difference 15.69 (11.26, 20.11)
11.1 hours
 Increase PA 28.6 28.8 10.23 (7.57, 12.88)
 Decrease SB 28.6 31.0 2.36 ( 0.17, 4.90)
 Difference 7.87 (4.34, 11.39)
p-value for three-way tx by time by average day length interaction 0.002
a

Average day length reported represents average day length for each seasonal period in Table 2. Continuous variable of average day length used in regression equation. Season not controlled for in analysis.

tx, treatment; PA, physical activity; SB, sedentary behavior